Skandinaviska Enskilda Banken (SEB)
THTX

Skandinaviska Enskilda Banken (SEB)’s Theratechnologies THTX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-352,986
Closed -$1.2M – 821
2025
Q3 		$1.2M Buy
352,986
+220,347
+166% +$703K ﹤0.01% 617
2025
Q2 		$313K Buy
+132,639
New +$325K ﹤0.01% 729

Skandinaviska Enskilda Banken (SEB)'s THTX Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Theratechnologies (THTX) in Q4 2025, closing a stake of 352,986 shares — an estimated $1.2M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in THTX in Q2 2025 and held it in 2 quarters. The position peaked at $1.2M in Q3 2025. 0 funds tracked by Wall St. Rank hold THTX as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Theratechnologies position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 352,986 Theratechnologies shares in Q4 2025, an estimated $1.2M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Theratechnologies in Q2 2025 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Theratechnologies position peaked at $1.2M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.